Gong G - Search Results

1

Re: On the use of familial aggregation in population-based case probands for calculating penetrance.

Whittemore AS, Gong G. Whittemore AS, et al. Among authors: gong g. J Natl Cancer Inst. 2003 Jan 1;95(1):76-7; author reply 77-8. doi: 10.1093/jnci/95.1.76. J Natl Cancer Inst. 2003. PMID: 12509408 No abstract available.

2

Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.

Gong G, Whittemore AS. Gong G, et al. Genet Epidemiol. 2003 Apr;24(3):173-80. doi: 10.1002/gepi.10219. Genet Epidemiol. 2003. PMID: 12652521

3

Estimating gene penetrance from family data.

Gong G, Hannon N, Whittemore AS. Gong G, et al. Genet Epidemiol. 2010 May;34(4):373-81. doi: 10.1002/gepi.20493. Genet Epidemiol. 2010. PMID: 20397150 Free PMC article.

4

Estimating genetic influence on disease from population-based case-control data: application to cancers of the breast and ovary.

Gong G, Whittemore AS. Gong G, et al. Stat Med. 1999 Dec 15;18(23):3321-36. doi: 10.1002/(sici)1097-0258(19991215)18:23<3321::aid-sim319>3.0.co;2-z. Stat Med. 1999. PMID: 10602154

5

Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer.

Whittemore AS, Gong G, Itnyre J. Whittemore AS, et al. Among authors: gong g. Am J Hum Genet. 1997 Mar;60(3):496-504. Am J Hum Genet. 1997. PMID: 9042908 Free PMC article.

6

Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry.

Kurian AW, Gong GD, John EM, Johnston DA, Felberg A, West DW, Miron A, Andrulis IL, Hopper JL, Knight JA, Ozcelik H, Dite GS, Apicella C, Southey MC, Whittemore AS. Kurian AW, et al. J Clin Oncol. 2011 Dec 1;29(34):4505-9. doi: 10.1200/JCO.2010.34.4440. Epub 2011 Oct 31. J Clin Oncol. 2011. PMID: 22042950 Free PMC article.

7

Performance of prediction models for BRCA mutation carriage in three racial/ethnic groups: findings from the Northern California Breast Cancer Family Registry.

Kurian AW, Gong GD, John EM, Miron A, Felberg A, Phipps AI, West DW, Whittemore AS. Kurian AW, et al. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1084-91. doi: 10.1158/1055-9965.EPI-08-1090. Epub 2009 Mar 31. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19336551 Free PMC article. Clinical Trial.

8

Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites.

Whittemore AS, Gong G, John EM, McGuire V, Li FP, Ostrow KL, Dicioccio R, Felberg A, West DW. Whittemore AS, et al. Among authors: gong g. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2078-83. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598764

9

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.

John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, West DW, Whittemore AS. John EM, et al. Among authors: gong g. JAMA. 2007 Dec 26;298(24):2869-76. doi: 10.1001/jama.298.24.2869. JAMA. 2007. PMID: 18159056

10

Performance of BRCA1/2 mutation prediction models in Asian Americans.

Kurian AW, Gong GD, Chun NM, Mills MA, Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, Ridge Y, Panabaker K, West DW, Whittemore AS, Ford JM. Kurian AW, et al. J Clin Oncol. 2008 Oct 10;26(29):4752-8. doi: 10.1200/JCO.2008.16.8310. Epub 2008 Sep 8. J Clin Oncol. 2008. PMID: 18779604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results